维普中文期刊产品整合服务
21篇 您的检索式:作者名="REMONDO C"
    题名 作者 年代 出处 被引量
1Dose/dense metro- nomic chemotherapy with fractioned cisplatin and oral daily etopo- side enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients显示文摘Correale P Remondo C Carbone SF 2010Cancer Biol Ther2010,9,9:1
2Second - line treatment of non small cell lung cancer byweekly gemcit - abine and docetaxel +/- granulocyte - macrophage colony stmiulating factor and low dose al- desleukine显示文摘Correale P Miano ST Remondo C 2009Cancer Biol Ther2009,8,:1
3Dose/dense metro- nomic chemotherapy with fractioned cisplatin and oral daily e- toposide enhances the antiangiogenic effects of bevacizumab and has strong antitumor activity in advanced nonsmall-cell-lung cancer patients显示文摘Correale P Remondo C Carbone S F 2010Cancer Biol Ther2010,9,9:1
4A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients显示文摘Correale P Cerretani D Remondo C 2006Oncol Rep2006,16,1:1
5Human dendritic cell maturation and activation by a heatkilled recombinant yeast (Saccharomyces cerevisiae ) vector encoding carcinoembryonic antigen 显示文摘Remondo C Ceredaa V Mostbock S 2009Vaccine2009,27,:1
6Cytotoxic drugs up-regu-late epidermal growth factor receptor (EGFR)expression in colon cancer cells and enhance their susceptibility to EGFR-targeted anti-body-dependent cell-mediated-cytotoxicity (ADCC)显示文摘Correale P Marra M Remondo C 0,,09:1
7A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients 显示文摘Correale P Cerretani D Remondo C 2006Oncol Rep2006,16,1:1
8Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients 显示文摘Correale P Remondo C Carbone SF et at 2010Cancer Biol Ther2010,9,9:1
9Cytotoxic drugs up-regulate epidermal growth factor receptor(EGFR)expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity(ADCC)显示文摘Correale P Marra M Remondo C 2010Eur J Cancer2010,46,9:1
10Enhanced functionality of CD4^+ CD25 (high)FOXP3+ regulatory T cells in the peripheral blood of patients with prostate cancer 显示文摘Yokokawa J Cereda V Remondo C 2008Clin Cancer Res2008,14,:1
11A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients显示文摘Correale P Cerretani D Remondo C 2006Oneol Rep2006,16,1:1
12Cytotoxic drugs up-regulate epidermal growth factor receptor(EGFR)expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity(ADCC)显示文摘Correale P Marra M Remondo C 2010Eur J Cancer2010,46,9:1
13Dose/dense metro nomic chemotherapy with fractioned cisplatin and oral daily eto poside enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non small-cell-lung cancer patients显示文摘Correale P Remondo C Carbone S F 2010Cancer Biol Ther2010,9,9:1
14Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer显示文摘YokokawaJ Cereda V Remondo C 2008Clin Cancer Res2008,14,4:1
15Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients显示文摘Correale P Remondo C Carbone SF 2010Cancer Biol Ther2010,9,9:1
16A novelmetronomic chemotherapy regimen ofweekly platinum and daily oral etoposide in high - risk non - small cell lung cancer patients 显示文摘Coneale P Cerretani D Remondo C 2006Oncol Rep2006,,:1
17A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients显示文摘Correale P Cerretani D Remondo C 2006Oncol Rep2006,164,:1
18Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediatad-cytotoxicity (ADCC)显示文摘Correale P Marra M Remondo C 2010Eur J Cancer2010,46,9:1
19Second-line treat- ment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating fac- tor and low dose aldesleukine 显示文摘Correale P Miano ST Remondo C 2009Cancer Biol Ther2009,8,6:1
20Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer显示文摘YOKOKAWA J CEREDA V REMONDO C 2008Clin Cancer Res2008,14,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费